Texas Network of Centers for Interventional Psychiatry (TNCIP)
TNCIP is an emerging statewide collaborative initiative designed to connect academic and clinical centers in Texas that deliver advanced, evidence-based interventional psychiatry care for patients with severe, complex, and treatment-resistant psychiatric disorders.
Vision
To establish Texas as a national leader in interventional psychiatry, ensuring equitable access to high-quality, data-driven, and innovative treatments across the state.
Mission
To unify Texas-based interventional psychiatry programs through:
- Clinical collaboration
- Standardized care pathways
- Education and workforce development
- Multi-site research and innovation
- Coordinated referral and access
Core Pillars
- Clinical Excellence
- Shared standards for ECT, TMS, ketamine/esketamine, neuromodulation, and emerging interventions
- Harmonized protocols for treatment-resistant depression and related conditions
- Access & Referral Network
- Clear referral pathways across Texas
- Regional hubs and spoke sites to reduce geographic barriers
- Education & Training
- Interventional psychiatry fellowships, electives, and CME
- Cross-institutional case conferences and didactics
- Research & Data Collaboration
- Multi-center clinical trials and real-world outcomes registries
- Translational and biomarker-driven research initiatives
- Advocacy & Health Policy
- Reimbursement alignment
- State-level engagement on access to advanced psychiatric care
Potential Founding/Anchor Centers
- Academic and health-system–based interventional psychiatry programs across Texas
- Anchored initially by leaders such as the UTHealth Houston Center for Interventional Psychiatry, with expansion to other UT System campuses, Baylor-affiliated sites, and major health systems
Why TNCIP Matters
- Texas has scale, diversity, and unmet need — ideal for a coordinated interventional psychiatry network
- Aligns with national models (e.g., NNDC) while addressing Texas-specific access gaps
- Positions the state for large-scale funding, trials, and policy influence